AI assistant
UroGen Pharma Ltd. — Director's Dealing 2024
Feb 2, 2024
32312_dirs_2024-02-02_1b3a3b72-e958-49af-99e5-a08da396f496.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UroGen Pharma Ltd. (URGN)
CIK: 0001668243
Period of Report: 2024-01-31
Reporting Person: Smith Jason Drew (General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-01-31 | Ordinary Shares | M | 834 | — | Acquired | 19241 | Direct |
| 2024-01-31 | Ordinary Shares | S | 417 | $15.74 | Disposed | 18824 | Direct |
| 2024-01-31 | Ordinary Shares | M | 2500 | — | Acquired | 21324 | Direct |
| 2024-01-31 | Ordinary Shares | S | 1248 | $15.74 | Disposed | 20076 | Direct |
| 2024-01-31 | Ordinary Shares | M | 6666 | — | Acquired | 26742 | Direct |
| 2024-01-31 | Ordinary Shares | S | 3328 | $15.74 | Disposed | 23414 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-01-31 | Restricted Stock Units | $ | M | 834 | Disposed | Ordinary Shares (834) | Direct | |
| 2024-01-31 | Restricted Stock Units | $ | M | 2500 | Disposed | Ordinary Shares (2500) | Direct | |
| 2024-01-31 | Restricted Stock Units | $ | M | 6666 | Disposed | Ordinary Shares (6666) | Direct | |
| 2024-01-31 | Restricted Stock Units | $ | A | 16500 | Acquired | Ordinary Shares (16500) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
F2: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
F3: The reporting person was granted RSUs on January 31, 2021 representing 2,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022.
F4: The reporting person was granted RSUs on January 31, 2022 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023.
F5: The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024.
F6: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027.